Free Trial

Xtant Medical (XTNT) Stock Forecast & Price Target

Xtant Medical logo
$0.53
0.00 (-0.13%)
(As of 09:32 AM ET)

Xtant Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Xtant Medical in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for XTNT.

Consensus Price Target

$2.25
321.98% Upside
According to the 2 analysts' twelve-month price targets for Xtant Medical, the average price target is $2.25. The highest price target for XTNT is $3.00, while the lowest price target for XTNT is $1.50. The average price target represents a forecasted upside of 321.98% from the current price of $0.53.
Get the Latest News and Ratings for XTNT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xtant Medical and its competitors.

Sign Up

XTNT Analyst Ratings Over Time

TypeCurrent Forecast
11/6/23 to 11/5/24
1 Month Ago
10/7/23 to 10/6/24
3 Months Ago
8/8/23 to 8/7/24
1 Year Ago
11/6/22 to 11/6/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.25$3.00$3.00$1.20
Forecasted Upside321.98% Upside154.24% Upside154.24% Upside1.69% Upside
Consensus Rating
Buy
Buy
Buy
Buy

XTNT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XTNT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xtant Medical Stock vs. The Competition

TypeXtant MedicalMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.79
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside321.98% Upside16,383.89% Upside10.49% Upside
News Sentiment Rating
Positive News

See Recent XTNT News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/18/2024Craig Hallum
3 of 5 stars
Chase Knickerbocker
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy ➝ Buy$1.50+160.87%
5/16/2024BTIG Research
2 of 5 stars
 Boost TargetBuy ➝ Buy$2.00 ➝ $3.00+279.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:55 AM ET.


XTNT Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Xtant Medical is $2.25, with a high forecast of $3.00 and a low forecast of $1.50.

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xtant Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" XTNT shares.

According to analysts, Xtant Medical's stock has a predicted upside of 322.54% based on their 12-month stock forecasts.

Xtant Medical has been rated by research analysts at Craig Hallum in the past 90 days.

Analysts like Xtant Medical more than other "medical" companies. The consensus rating for Xtant Medical is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how XTNT compares to other companies.


This page (NYSEAMERICAN:XTNT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners